Market LIVE
Published markets; coverage varies by country
Product profile · United States

POSLUMA

 ·  Patent Litigation & Settlement History ↓

IngredientFLOTUFOLASTAT F-18 GALLIUM
Application typeNDA
Application216023
Product001
Dosage formSOLUTION
RouteINTRAVENOUS
Strength25ML (8-158mCi/ML)
Approval date2023-05-25
Marketing statusPrescription
Status event—
ApplicantBLUE EARTH
Product source

Current GenericRadar decision

Year2023
SelectionEXCLUDED
ReviewFINAL
Anchor typeAPPROVAL_DATE
Anchor date2023-05-25
Patent anchor2038-11-22
Exclusivity anchor2028-05-25
Protection date2041-11-27
First Final ANDA—
Status event—

GNR judgment: EXCLUDED. Reference year: 2023. Anchor type: APPROVAL_DATE. Patent anchor: 2038-11-22. Exclusivity anchor: 2028-05-25. Anchor date: 2023-05-25. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
123905402038-08-23DS —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
123905402038-08-23ORANGE_BOOK —YNTRUE_DS
English description not available.
———
114133602038-11-22DS/U U-3614YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
114133602038-11-22DS/U U-3615YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
114133602038-11-22ORANGE_BOOK U-3614;U-3615YNTRUE_DS
English description not available.
———
123577112038-11-22DS —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
123577112038-11-22ORANGE_BOOK —YNTRUE_DS
English description not available.
———
123771762038-11-22DS —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
123771762038-11-22ORANGE_BOOK —YNTRUE_DS
English description not available.
———
120362902041-11-27DP/U U-3615NNDP
| B1C03 issued-claim review2026-10-15: DP
———
120362902041-11-27DP/U U-3614NNDP
| B1C03 issued-claim review2026-10-15: DP
———
120362902041-11-27ORANGE_BOOK U-3614;U-3615NNDP
English description not available.
———
124272072041-11-27DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
124272072041-11-27ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2023-05-252028-05-25English description not available.YY2028-05-25—Source
NCE2023-05-252028-05-25English description not available.YY2028-05-25
NCE
Full coverage date: 2028-05-25
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (8)
TypeDateRoleBasisSource
PATENT2038-08-23HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2038-11-22HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2038-11-22HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2038-11-22HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2041-11-27HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2041-11-27HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2023-05-25TERMINAL_STATUSEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.